Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
phat
/
Phathom Pharmaceuticals Inc
PHAT
Add to Watchlist
8.930
USD
+0.180
+2.06%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 08/03, 09:30 (ET)
715.03M
Market Cap
Loss
P/E TTM
Phathom Pharmaceuticals Inc
8.930
+0.180
+2.06%
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Frazier Life Sciences Management, L.P.
15.63%
Medicxi Ventures (UK) LLP
9.36%
Millennium Management LLC
5.24%
Abingworth Management Limited
4.38%
Invesco Advisers, Inc.
3.99%
Other
61.39%
Shareholders
Shareholders
Proportion
Frazier Life Sciences Management, L.P.
15.63%
Medicxi Ventures (UK) LLP
9.36%
Millennium Management LLC
5.24%
Abingworth Management Limited
4.38%
Invesco Advisers, Inc.
3.99%
Other
61.39%
Shareholder Types
Shareholders
Proportion
Investment Advisor
22.16%
Venture Capital
19.25%
Private Equity
16.16%
Investment Advisor/Hedge Fund
12.43%
Hedge Fund
11.55%
Individual Investor
4.60%
Research Firm
1.65%
Bank and Trust
0.26%
Pension Fund
0.10%
Other
11.83%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
354
69.84M
87.57%
-14.23M
2025Q4
328
60.04M
77.11%
-25.29M
2025Q3
315
60.57M
85.19%
-24.26M
2025Q2
318
61.93M
88.60%
-20.64M
2025Q1
321
68.36M
98.42%
-14.76M
2024Q4
311
70.95M
103.79%
-11.79M
2024Q3
293
76.11M
113.29%
+9.50M
2024Q2
284
61.82M
105.14%
-1.53M
2024Q1
280
58.85M
100.56%
-3.74M
2023Q4
274
57.52M
100.58%
-4.32M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Frazier Life Sciences Management, L.P.
12.47M
15.82%
+276.03K
+2.26%
Dec 31, 2025
Medicxi Ventures (UK) LLP
7.46M
9.47%
--
--
Dec 31, 2025
Millennium Management LLC
4.18M
5.3%
+2.10M
+100.67%
Mar 06, 2026
Abingworth Management Limited
3.50M
4.44%
--
--
Dec 31, 2025
Invesco Advisers, Inc.
3.19M
4.04%
-45.33K
-1.40%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.14M
3.99%
+86.29K
+2.82%
Dec 31, 2025
Ensign Peak Advisors, Inc.
2.35M
2.98%
-151.32K
-6.04%
Dec 31, 2025
New Enterprise Associates (NEA)
1.96M
2.49%
--
--
Dec 31, 2025
683 Capital Management LLC
1.78M
2.27%
-35.38K
-1.94%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Simplify Propel Opportunities ETF
6.45%
Virtus LifeSci Biotech Products ETF
2.16%
State Street SPDR S&P Pharmaceuticals ETF
1.37%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.35%
Invesco Dorsey Wright Healthcare Momentum ETF
0.92%
Invesco Dorsey Wright SmallCap Momentum ETF
0.53%
iShares U.S. Pharmaceuticals ETF
0.23%
ProShares Ultra Nasdaq Biotechnology
0.13%
iShares Micro-Cap ETF
0.11%
Invesco Nasdaq Biotechnology ETF
0.1%
View more
Simplify Propel Opportunities ETF
Proportion
6.45%
Virtus LifeSci Biotech Products ETF
Proportion
2.16%
State Street SPDR S&P Pharmaceuticals ETF
Proportion
1.37%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion
1.35%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion
0.92%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion
0.53%
iShares U.S. Pharmaceuticals ETF
Proportion
0.23%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.13%
iShares Micro-Cap ETF
Proportion
0.11%
Invesco Nasdaq Biotechnology ETF
Proportion
0.1%